Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Aug 1;373(Pt 3):835–843. doi: 10.1042/BJ20021829

Functional characterization of the human phosphodiesterase 7A1 promoter.

Mònica Torras-Llort 1, Fernando Azorín 1
PMCID: PMC1223549  PMID: 12737631

Abstract

In this paper, the human phosphodiesterase 7A1 (h PDE7A1 ) promoter region was identified and functionally characterized. Transient transfection experiments indicated that a 2.9 kb fragment of the h PDE7A1 5'-flanking region, to position -2907, has strong promoter activity in Jurkat T-cells. Deletion analysis showed that the proximal region, up to position -988, contains major cis -regulatory elements of the h PDE7A1 promoter. This minimal promoter region contains a regulatory CpG island which is essential for promoter activity. The CpG island contains three potential cAMP-response-element-binding protein (CREB)-binding sites that, as judged by in vivo dimethyl sulphate (DMS) footprinting, are occupied in Jurkat T-cells. Moreover, over-expression of CREB results in increased promoter activity, but, on the other hand, promoter activity decreases when a dominant-negative form of CREB (KCREB) is over-expressed. In vivo DMS footprinting strongly indicates that other transcription factors, such Ets-2, nuclear factor of activated T-cells 1 (NFAT-1) and nuclear factor kappaB (NF-kappaB), might also contribute to the regulation of h PDE7A1 promoter. Finally, h PDE7A1 promoter was found to be induced by treatment with PMA, but not by treatment with dibutyryl cAMP or forskolin. These results provide insights into the factors and mechanisms that regulate expression of the h PDE7A gene.

Full Text

The Full Text of this article is available as a PDF (418.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Algarté M., Kwon H., Génin P., Hiscott J. Identification by in vivo genomic footprinting of a transcriptional switch containing NF-kappaB and Sp1 that regulates the IkappaBalpha promoter. Mol Cell Biol. 1999 Sep;19(9):6140–6153. doi: 10.1128/mcb.19.9.6140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Antequera F., Bird A. CpG islands as genomic footprints of promoters that are associated with replication origins. Curr Biol. 1999 Sep 9;9(17):R661–R667. doi: 10.1016/s0960-9822(99)80418-7. [DOI] [PubMed] [Google Scholar]
  3. Bird Adrian. DNA methylation patterns and epigenetic memory. Genes Dev. 2002 Jan 1;16(1):6–21. doi: 10.1101/gad.947102. [DOI] [PubMed] [Google Scholar]
  4. Bloom T. J., Beavo J. A. Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14188–14192. doi: 10.1073/pnas.93.24.14188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clark S. J., Harrison J., Paul C. L., Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 1994 Aug 11;22(15):2990–2997. doi: 10.1093/nar/22.15.2990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Conti M., Jin S. L. The molecular biology of cyclic nucleotide phosphodiesterases. Prog Nucleic Acid Res Mol Biol. 1999;63:1–38. doi: 10.1016/s0079-6603(08)60718-7. [DOI] [PubMed] [Google Scholar]
  7. Gardiner-Garden M., Frommer M. CpG islands in vertebrate genomes. J Mol Biol. 1987 Jul 20;196(2):261–282. doi: 10.1016/0022-2836(87)90689-9. [DOI] [PubMed] [Google Scholar]
  8. Glavas N. A., Ostenson C., Schaefer J. B., Vasta V., Beavo J. A. T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3. Proc Natl Acad Sci U S A. 2001 May 22;98(11):6319–6324. doi: 10.1073/pnas.101131098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Graef I. A., Chen F., Crabtree G. R. NFAT signaling in vertebrate development. Curr Opin Genet Dev. 2001 Oct;11(5):505–512. doi: 10.1016/s0959-437x(00)00225-2. [DOI] [PubMed] [Google Scholar]
  10. Grange T., Bertrand E., Espinás M. L., Fromont-Racine M., Rigaud G., Roux J., Pictet R. In vivo footprinting of the interaction of proteins with DNA and RNA. Methods. 1997 Feb;11(2):151–163. doi: 10.1006/meth.1996.0401. [DOI] [PubMed] [Google Scholar]
  11. Génin P., Algarté M., Roof P., Lin R., Hiscott J. Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors. J Immunol. 2000 May 15;164(10):5352–5361. doi: 10.4049/jimmunol.164.10.5352. [DOI] [PubMed] [Google Scholar]
  12. Han P., Fletcher C. F., Copeland N. G., Jenkins N. A., Yaremko L. M., Michaeli T. Assignment of the mouse Pde7A gene to the proximal region of chromosome 3 and of the human PDE7A gene to chromosome 8q13. Genomics. 1998 Mar 1;48(2):275–276. doi: 10.1006/geno.1997.5168. [DOI] [PubMed] [Google Scholar]
  13. Han P., Zhu X., Michaeli T. Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart. J Biol Chem. 1997 Jun 27;272(26):16152–16157. doi: 10.1074/jbc.272.26.16152. [DOI] [PubMed] [Google Scholar]
  14. Kasuya J., Liang S. J., Goko H., Park S. H., Kato K., Xu Z. D., Hockman S., Manganiello V. C., Fujita-Yamaguchi Y. Cardiac type cGMP-inhibited phosphodiesterase (PDE3A) gene structure: similarity and difference to adipocyte type PDE3B gene. Biochem Biophys Res Commun. 2000 Feb 24;268(3):827–834. doi: 10.1006/bbrc.2000.2226. [DOI] [PubMed] [Google Scholar]
  15. Lee Richard, Wolda Sharon, Moon Eunyi, Esselstyn James, Hertel Carmen, Lerner Adam. PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP. Cell Signal. 2002 Mar;14(3):277–284. doi: 10.1016/s0898-6568(01)00250-9. [DOI] [PubMed] [Google Scholar]
  16. Li L., Yee C., Beavo J. A. CD3- and CD28-dependent induction of PDE7 required for T cell activation. Science. 1999 Feb 5;283(5403):848–851. doi: 10.1126/science.283.5403.848. [DOI] [PubMed] [Google Scholar]
  17. Lin C. S., Chow S., Lau A., Tu R., Lue T. F. Identification and regulation of human PDE5A gene promoter. Biochem Biophys Res Commun. 2001 Jan 26;280(3):684–692. doi: 10.1006/bbrc.2000.4220. [DOI] [PubMed] [Google Scholar]
  18. Lin C. S., Lau A., Tu R., Lue T. F. Identification of three alternative first exons and an intronic promoter of human PDE5A gene. Biochem Biophys Res Commun. 2000 Feb 16;268(2):596–602. doi: 10.1006/bbrc.2000.2186. [DOI] [PubMed] [Google Scholar]
  19. Macleod K., Leprince D., Stehelin D. The ets gene family. Trends Biochem Sci. 1992 Jul;17(7):251–256. doi: 10.1016/0968-0004(92)90404-w. [DOI] [PubMed] [Google Scholar]
  20. Montminy M. Transcriptional regulation by cyclic AMP. Annu Rev Biochem. 1997;66:807–822. doi: 10.1146/annurev.biochem.66.1.807. [DOI] [PubMed] [Google Scholar]
  21. Muramatsu M., Kaibuchi K., Arai K. A protein kinase C cDNA without the regulatory domain is active after transfection in vivo in the absence of phorbol ester. Mol Cell Biol. 1989 Feb;9(2):831–836. doi: 10.1128/mcb.9.2.831-836.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nakata A., Ogawa K., Sasaki T., Koyama N., Wada K., Kotera J., Kikkawa H., Omori K., Kaminuma O. Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitors. Clin Exp Immunol. 2002 Jun;128(3):460–466. doi: 10.1046/j.1365-2249.2002.01856.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Seybold J., Newton R., Wright L., Finney P. A., Suttorp N., Barnes P. J., Adcock I. M., Giembycz M. A. Induction of phosphodiesterases 3B, 4A4, 4D1, 4D2, and 4D3 in Jurkat T-cells and in human peripheral blood T-lymphocytes by 8-bromo-cAMP and Gs-coupled receptor agonists. Potential role in beta2-adrenoreceptor desensitization. J Biol Chem. 1998 Aug 7;273(32):20575–20588. doi: 10.1074/jbc.273.32.20575. [DOI] [PubMed] [Google Scholar]
  24. Shaywitz A. J., Greenberg M. E. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem. 1999;68:821–861. doi: 10.1146/annurev.biochem.68.1.821. [DOI] [PubMed] [Google Scholar]
  25. Soderling S. H., Beavo J. A. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr Opin Cell Biol. 2000 Apr;12(2):174–179. doi: 10.1016/s0955-0674(99)00073-3. [DOI] [PubMed] [Google Scholar]
  26. Taylor R. E., Shows K. H., Zhao Y., Pittler S. J. A PDE6A promoter fragment directs transcription predominantly in the photoreceptor. Biochem Biophys Res Commun. 2001 Mar 30;282(2):543–547. doi: 10.1006/bbrc.2001.4605. [DOI] [PubMed] [Google Scholar]
  27. Vicini E., Conti M. Characterization of an intronic promoter of a cyclic adenosine 3',5'-monophosphate (cAMP)-specific phosphodiesterase gene that confers hormone and cAMP inducibility. Mol Endocrinol. 1997 Jun;11(7):839–850. doi: 10.1210/mend.11.7.9941. [DOI] [PubMed] [Google Scholar]
  28. Walton K. M., Rehfuss R. P., Chrivia J. C., Lochner J. E., Goodman R. H. A dominant repressor of cyclic adenosine 3',5'-monophosphate (cAMP)-regulated enhancer-binding protein activity inhibits the cAMP-mediated induction of the somatostatin promoter in vivo. Mol Endocrinol. 1992 Apr;6(4):647–655. doi: 10.1210/mend.6.4.1350057. [DOI] [PubMed] [Google Scholar]
  29. Wang P., Wu P., Egan R. W., Billah M. M. Cloning, characterization, and tissue distribution of mouse phosphodiesterase 7A1. Biochem Biophys Res Commun. 2000 Oct 5;276(3):1271–1277. doi: 10.1006/bbrc.2000.3613. [DOI] [PubMed] [Google Scholar]
  30. Xie H., Rothstein T. L. Protein kinase C mediates activation of nuclear cAMP response element-binding protein (CREB) in B lymphocytes stimulated through surface Ig. J Immunol. 1995 Feb 15;154(4):1717–1723. [PubMed] [Google Scholar]
  31. Yamamoto K. K., Gonzalez G. A., Biggs W. H., 3rd, Montminy M. R. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature. 1988 Aug 11;334(6182):494–498. doi: 10.1038/334494a0. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES